Verrica Pharmaceuticals (NASDAQ:VRCA) Earns “Neutral” Rating from HC Wainwright
HC Wainwright restated their neutral rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a report published on Tuesday,Benzinga reports. Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Verrica Pharmaceuticals in a research note on Wednesday, March 12th. Four analysts have rated the stock with a hold rating and […]
